MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1699.13%
Quick Ratio
1699.13%
Cash Ratio
386.63%
Debt to Asset Ratio
21.36%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Less accumulated depreciation
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Long-term lease liability
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
288,291 294,944 267,960 282,132
Marketable securities
923,361 950,266 807,010 868,205
Prepaid expenses and other current assets
55,301 23,478 23,577 25,127
Total current assets
1,266,953 1,268,688 1,098,547 1,175,464
Total property and equipment
200,979 198,627 196,891 NaN
Less accumulated depreciation
99,732 94,127 88,601 NaN
Property and equipment, net
101,247 104,500 108,290 108,824
Restricted cash
6,693 6,676 6,656 6,633
Operating lease right-of-use assets
98,148 100,679 96,995 99,568
Other assets
7,757 634 593 668
Total assets
1,480,798 1,481,177 1,311,081 1,391,157
Accounts payable
12,286 10,231 9,545 10,556
Accrued expenses and other current liabilities
39,291 55,267 42,314 40,904
Current portion of derivative liabilities
5,200 7,700 6,500 3,900
Current portion of deferred revenue
304 6,659 110,320 105,822
Current portion of lease liability
14,781 14,364 12,688 12,949
Current portion of contingent consideration liabilities
2,703 2,714 1,192 NaN
Total current liabilities
74,565 96,935 182,559 174,131
Long-term lease liability
135,848 139,759 138,732 141,854
Long-term portion of derivative liabilities
NaN 0 6,654 6,497
Long-term portion of deferred revenue
NaN 0 10,160 20,319
Long-term portion of contingent consideration liabilities
5,449 5,952 6,708 1,186
Long-term portion of debt
100,193 NaN NaN NaN
Other liabilities
305 173 266 357
Total liabilities
316,360 242,819 345,079 344,344
Common stock, 0.01 par value 250,000,000 shares authorized, 102,741,848 and 101,748,962 issued and outstanding at march 31, 2026 and december 31, 2025, respectively
1,027 1,017 1,014 1,008
Additional paid-in capital
2,900,018 2,877,449 2,855,118 2,823,987
Accumulated other comprehensive (loss) income
-1,070 1,111 790 10
Accumulated deficit
-1,735,537 -1,641,219 -1,890,920 -1,778,192
Total stockholders' equity
1,164,438 1,238,358 966,002 1,046,813
Total liabilities and stockholders' equity
1,480,798 1,481,177 1,311,081 1,391,157
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$923,361K Cash and cashequivalents$288,291K Prepaid expenses andother current assets$55,301K Total property andequipment$200,979K Total current assets$1,266,953K Property and equipment,net$101,247K Operating leaseright-of-use assets$98,148K Other assets$7,757K Restricted cash$6,693K Less accumulateddepreciation$99,732K Total assets$1,480,798K Total liabilities andstockholders' equity$1,480,798K Total stockholders'equity$1,164,438K Total liabilities$316,360K Accumulated deficit-$1,735,537K Accumulated othercomprehensive (loss) income-$1,070K Additional paid-in capital$2,900,018K Long-term lease liability$135,848K Long-term portion of debt$100,193K Total currentliabilities$74,565K Long-term portion ofcontingent consideration...$5,449K Other liabilities$305K Common stock, 0.01 parvalue 250,000,000...$1,027K Accrued expenses andother current...$39,291K Current portion of leaseliability$14,781K Accounts payable$12,286K Current portion ofderivative liabilities$5,200K Current portion ofcontingent consideration...$2,703K Current portion ofdeferred revenue$304K

Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Inc. (BEAM)